Unicentric form of Castleman´s disease, pitfalls of diagnosis and surgical treatment

Background Castleman´s disease is an extremely rare heterogenous lymphoproliferative pathology with a mostly benign behavior. It is a localized or generalized lymph node enlargement of an unknown aetiology. Unicentric form is typically a slow-growing solitary mass occurring mostly in the mediastinum, abdominal cavity, retroperitoneum, pelvis and neck. Aetiology and pathogenesis of CD is probably diverse, varying in different types of this heterogeneous disease. Materials and Methods Authors present a review of this issue based on their extensive experience. The aim is to summarize the crucial factors in the management of diagnostics and a surgical treatment of the unicentric form of Castleman´s disease. One of the key issues in the unicentric form is precise preoperative diagnostics and thus choosing the right surgical treatment strategy. Authors highlight pitfalls of the diagnosis and surgical treatment. Results All histological types such as a hyaline vascular type, plasmacytic type and a mixed type are presented as well as options of surgical and conservative treatment. Differential diagnosis and malignant potential is discussed. Conclusion Patients with Castleman´s disease should be treated in the high- volume centers, with a great experience in major surgical procedures as well as with preoperative imaging diagnostic techniques. Specialized pathologists and oncologists focusing on this issue are also absolutely necessary to avoid misdiagnosis. Only this complex approach can lead to excellent outcomes in patients with UCD.

[1]  N. Munshi,et al.  International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. , 2020, Blood advances.

[2]  C. Tayar,et al.  Unicentric Castleman’s Disease: Laparoscopic Approach of a Para-Duodenal Retroperitoneal Mass , 2020, The American journal of case reports.

[3]  A. Dispenzieri,et al.  Overview of Castleman Disease. , 2020, Blood.

[4]  É. Oksenhendler,et al.  Epidemiology of Castleman disease associated with AA amyloidosis: description of 2 new cases and literature review , 2019, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[5]  É. Oksenhendler,et al.  Treatment and outcome of Unicentric Castleman Disease: a retrospective analysis of 71 cases , 2019, British journal of haematology.

[6]  D. Shilling,et al.  Castleman Disease Pathogenesis. , 2018, Hematology/oncology clinics of North America.

[7]  D. Simpson Epidemiology of Castleman Disease. , 2018, Hematology/oncology clinics of North America.

[8]  R. Wong Unicentric Castleman Disease. , 2018, Hematology/oncology clinics of North America.

[9]  L. Vercellino,et al.  The full spectrum of Castleman disease: 273 patients studied over 20 years , 2018, British journal of haematology.

[10]  F. Sbrana,et al.  Castleman’s disease: a rare presentation in a retroperitoneal accessory spleen, treated with a minimally invasive robotic approach , 2017, Journal of surgical case reports.

[11]  D. Tobin,et al.  Demographic Characteristics and Association of Serum Vitamin B12, Ferritin and Thyroid Function with Premature Canities in Indian Patients from an Urban Skin Clinic of North India: A Retrospective Analysis of 71 Cases , 2017, Indian journal of dermatology.

[12]  T. Troiani,et al.  Laparoscopic treatment of abdominal unicentric castleman’s disease: a case report and literature review , 2017, BMC Surgery.

[13]  B. Knebelmann,et al.  Case report and literature review , 2016, Medicine.

[14]  N. Munshi,et al.  Use of a claims database to characterize and estimate the incidence rate for Castleman disease , 2015, Leukemia & lymphoma.

[15]  D. Weisenburger,et al.  The clinical spectrum of Castleman's disease , 2012, American journal of hematology.

[16]  K. Schulte,et al.  Surgery in Castleman's Disease: A Systematic Review of 404 Published Cases , 2012, Annals of surgery.

[17]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[18]  K. Schulte,et al.  Castleman's disease: systematic analysis of 416 patients from the literature. , 2011, The oncologist.

[19]  B. Castleman,et al.  Localized mediastinal lymph‐node hyperplasia resembling thymoma , 1956, Cancer.

[20]  N. Panagiotopoulos,et al.  The role of surgical resection in Unicentric Castleman's disease: a systematic review. , 2018, Advances in respiratory medicine.

[21]  B. Roca Castleman's Disease. A Review. , 2009, AIDS reviews.